Thursday, 25 August 2022

Glenmark Pharma gets OAI for US based plant

Glenmark Pharma gets OAI for US based plant
Glenmark Pharma gets OAI for US based plant

Glenmark Pharma Monroe, North Carolina (USA) based Facility has received a communication from the US FDA indicating the inspection classification as Official Action Indicated (OAI).

The OAI classification implies interalia that the US FDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved.

Pradip Mahajan Thu, 08/25/2022 - 12:06

source https://www.pharmatutor.org/pharma-news/2022/glenmark-pharma-gets-official-action-indicated-oai-for-monroe-usa-based-plant

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...